Results 191 to 200 of about 156,767 (359)

Etiology, pathogenesis and treatment of peri‐implantitis: A European perspective

Periodontology 2000, EarlyView.
Abstract Peri‐implantitis is a plaque‐associated pathological condition occurring in tissues around dental implants. It is characterized by inflammation in the peri‐implant mucosa and progressive loss of supporting bone. Over the last 30 years, peri‐implantitis has become a major disease burden in dentistry.
Tord Berglundh, Andrea Mombelli, Frank Schwarz, Jan Derks   +3 more
wiley   +1 more source

Serum tissue plasminogen activator after cycling with blood flow restriction. [PDF]

Vasc Biol
Landers JB, Allen M, Oladele I, Lowe L, Ali N, Rainey J, Fletcher J, Landers K.   +7 more
europepmc   +1 more source

Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.

, 1989
Desmond J. Fitzgerald, Garret A. FitzGerald   +1 more
openalex   +1 more source

Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics. [PDF]

, 1989
Richard M. Prewitt, F.H. Shiffman, David H. Greenberg, Robert A. Cook, John Ducas   +4 more
openalex   +1 more source

Genetic risk variants implicate impaired maintenance and repair of periodontal tissues as causal for periodontitis—A synthesis of recent findings

Periodontology 2000, EarlyView.
AbstractPeriodontitis is a complex inflammatory disease in which the host genome, in conjunction with extrinsic factors, determines susceptibility and progression. Genetic predisposition is the strongest risk factor in the first decades of life. As people age, chronic exposure to the periodontal microbiome puts a strain on the proper maintenance of ...
Arne S. Schaefer, Luigi Nibali, Noha Zoheir, Niki M. Moutsopoulos, Bruno G. Loos   +4 more
wiley   +1 more source

Tissue Plasminogen Activator (tPA) Use in Persistent Loculated Ascites. [PDF]

Cureus
Ali KM, Molloy R, Friedman A, Srikureja W, Bent C, Garrison RC.   +5 more
europepmc   +1 more source

Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium. [PDF]

, 1988
Allan M. Lefer, Richard K. Mentley, Jun Sun   +2 more
openalex   +1 more source

Clot formation and resolution properties of platelets during cold storage for 21 days

Transfusion, EarlyView.
Abstract Background Cold storage (2–6°C) preserves the aggregatory and clot formation properties of platelets beyond the standard 7‐day shelf life. Comparatively little is known about the effect of cold storage on clot resolution functions, which are necessary to ensure normal hemostatic balance is maintained.
Janhavi Mahajan, Matthew P. Padula, Denese C. Marks, Lacey Johnson   +3 more
wiley   +1 more source

Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transformation After Ischemic Stroke. [PDF]

CNS Neurosci Ther
Xie G, Jiang G, Huang L, Sun S, Li X, Wu B, Wang H, Zhang Z, Ye K, Yu Y, Xiong J.   +10 more
europepmc   +1 more source

Release of tissue‐type plasminogen activator is induced in rats by leukotrienes C₄ and D₄, but not by prostaglandins E₁, E₂ and I₂ [PDF]

, 1988
N. Tranquille, J.J. Emeis
openalex   +1 more source